In the Zone

 

$BTAI – BioXcel Therapeutics, Inc.

 

BioXcel Therapeutics is a Nasdaq listed biopharmaceutical 

company that is headquartered in New Haven Connecticut that 

focuses on novel artificial intelligence based drugs development 

in the field if neuroscience and immuno-oncology.

 

If you have a close look at the a monthly stock chart for the company

you will notice that this stock has been moving higher to the upside

for 9 of the past 12 months since November of 2019, coming from 

a price low of $3.76. The stock is currently up +1,181.88% YTD.

 

As for the past 7 months the stock has been trading in a sideways 

consolidation between the prices of 36.37 and 53.08. As for now 

this stock is poised to move higher so I suggest that its a stock to 

keep a close eye on going forward. What I am looking for is for a 

break out in price above $53.11 to $53.16.

 

At the close of trading on Friday the stock closed to end the day 

trading at 53.07 down $0.62 or -1.15% on lighter than average 

daily trading volume of 279,717. Despite the decline the stock is 

up 16.16% for the week and one to keep a close eye on in the 

days and weeks ahead, so please keep this stock on your watch 

list as a possible turnaround play above $53.11.

By Marlin Rolle

 

Please note that all the stocks listed are not a buy recommendations; please do your own due diligence or get help from a professional before trading.